Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT

Around half of patients with Hodgkin Lymphoma (HL) who progress or relapse through first line therapy can be cured with salvage chemotherapy followed by autologous stem cell transplant (ASCT). However, this leaves approximately 50% of patients that will relapse after ASCT. The pivotal phase II SG035...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2019-11, Vol.134 (Supplement_1), p.4018-4018
Hauptverfasser:	Chavda, Nikesh Dhiraj, Robinson, Stephen, Boumendil, Ariane, Khvedelidze, Irma, Finel, Hervé, Akhtar, Saad, Rauf, M S, Durakovic, Nadira, Vrhovac, Radovan, Musso, Maurizio, Brice, Pauline, Arat, Mutlu, Blaise, Didier, Collin, Matthew P., Romejko-Jarosinska, Joanna, Stamatoullas, Aspasia, Ozkurt, Zubeyde Nur, Robak, Tadeusz, Wahlin, Björn E, Wilson, Keith, Alma, Eleonora, Pastano, Rocco, Castagna, Luca, Bazarbachi, Ali, Ghesquieres, Hervé, Colita, Andrei, Montoto, Silvia
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!